Cas:110-36-1 Butyl myristate manufacturer & supplier

Chemical Name:Butyl myristate

CAS.NO:110-36-1

Synonyms:butyl tetradecanoate;Tetradecanoic acid, butyl ester;MFCD00015077;MYRISTIC ACID N-BUTYL ESTER;Myristic acid, butyl ester (8CI);n-Butyl myristate;Myristic Acid Butyl Ester;Butyl myristate;EINECS 203-759-8

Molecular Formula:C₁₈H₃₆O₂

Molecular Weight:284.477

HS Code:2915900090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:334.7±10.0 °C at 760 mmHg

Density:0.9±0.1 g/cm3

Index of Refraction:1.443

PSA:26.30000

Exact Mass:284.271515

LogP:8.15

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like butyl tetradecanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 203-759-8 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Butyl myristate Use and application,Myristic Acid Butyl Ester technical grade,usp/ep/jp grade.

Related News: It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. Butyl myristate manufacturer A number of UK citizens who failed to leave the coronavirus-struck Chinese city of Wuhan last week are now on a second flight to Europe, UK Foreign Secretary Dominic Raab said Sunday. Butyl myristate supplier It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. Butyl myristate vendor ICIG has agreed to offer employment to the unit��s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland. Butyl myristate factory On April 8, a group of employees filed an anonymous complaint internally alleging that an executive at its Branchburg, New Jersey, factory had altered documents required by the U.S. Food and Drug Administration.